Ask Warren

Genome&Company

314130 · KOSDAQ · ₩314130 · 지놈앤컴퍼니

₩3,640▼ ₩200 (5.21%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩25B₩28B₩14B₩14B₩451M
Cost of sales₩11B₩12B₩10B₩8.5B₩77M
Gross profit₩13B₩16B₩4.1B₩5.6B₩374M
Operating income−₩29B−₩24B−₩55B−₩58B−₩36B
Net income−₩7.7B−₩27B−₩51B−₩57B−₩36B
Net income to shareholders−₩6.4B−₩20B−₩47B−₩52B−₩34B

Balance sheet

20252024202320222021
Total assets₩145B₩147B₩162B₩173B₩137B
Current assets₩52B₩92B₩97B₩117B₩82B
Cash and equivalents₩16B₩66B₩56B₩72B₩36B
Total liabilities₩30B₩48B₩49B₩22B₩24B
Current liabilities₩23B₩30B₩28B₩11B₩9.8B
Borrowings₩15B₩27B₩22B₩7B₩5.5B
Total equity₩115B₩99B₩114B₩151B₩113B
Shareholders' equity₩106B₩48B₩62B₩97B₩93B

Cash flow

20252024202320222021
Cash from operations−₩18B−₩16B−₩32B−₩44B−₩26B
Capital spending₩285M₩4B₩19B₩6.8B₩2.9B
Free cash flow−₩19B−₩20B−₩51B−₩50B−₩29B

Consolidated where available. Amounts in won.

Also known as: Genome&Company / 지놈앤컴퍼니 / 314130 / KRX:314130

Source: KRX statistical information